JWJianghua Wang

Jianghua Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jianghua Wang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Lai Wei

    Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China

    2 shared publications
  • Dong Jiang

    Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China

    1 shared publication
  • Dong Jiang

    Department of Sports Medicine, Peking University Third Hospital, Institute of Sports Medicine of Peking University, Beijing, China

    1 shared publication
  • Fei Ran

    Department of Cardiology, The First Affiliated Hospital, Chengdu Medical College, Chengdu, Sichuan 610500, China

    1 shared publication
  • Haiying Zhang

    Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University, Beijing, China

    1 shared publication
  • Henghui Zhang

    Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

    1 shared publication

Latest Publications

  • Research on Hotspot and Trend of Online Public Opinion Research in Big Data Environment

    by Jianghua Wang, Jianguo Tang

    In the era of big data, the features of online public opinion give some serious challenges for existing data analysis methods and it's necessary to give a review on the status and development trend of it. By means of CNKI, this paper collects published papers which involved in online public opinion research in big data Environment from 2010 to 2017.Using bibliometrics analysis and CiteSpace5.0 visualization application software, we get the hot spot and important frontier trend of online public opinion research in big data environment, on this basis, give a review on this research field. Some existing problems are analyzed and the future research direction of this filed are looked ahead. We hope this work can provide references for future related research and innovation.


  • Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein

    by Jianghua Wang, Haiying Zhang, Yingjun Zhang, Dong Jiang, Jing Li, Siegfried Goldmann, Qingyun Ren, Ran Fei, Xueyan Wang, Lai Wei

    Heteroaryldihydropyrimidine (HAP) compounds inhibit HBV replication by binding to a hydrophobic pocket at the interface between hepatitis B virus core protein (HBcAg) dimer, which interrupts capsid assembly by changing the kinetics and thermodynamics during this process. Structure biological studies have identified several amino acids in HBcAg crucial for compound binding. Here, we investigated the polymorphisms of T109 and V124 amino acids in HBV sequences submitted to GenBank database. Naturally occurring T109 and V124 and/or possible compensatory mutations in neighbored amino acids were introduced into HBV‐expressing plasmids. Viral replication competence and sensitivity to GLS4, a HAP compound, were evaluated using transient transfection and in vitro infection cell models. All tested mutations in these amino acids led to decreasing viral DNA replication at different levels. Specially, T109N and all V124 mutants caused severe deficiencies in viral plus‐strand DNA synthesis. T109I single mutation and all T109S/M/C/N mutations impaired HBeAg secretion. T109I showed modestly decreased sensitivities with IC50 3.3‐ to 6.8‐folds higher than wild‐type virus. In vitro infection assay showed T109N and all V124 mutants failed to synthesize cccDNA and following viral proteins. The other mutants, however, produced functional cccDNA pools as wild‐type virus did. Taken together, we profiled the competences of viral replication and sensitivities to capsid inhibitor of naturally existing mutations in T109 and V124. This will help to understand the possible antiviral resistance issues in future clinical applications of capsid inhibitors.


  • Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2

    by Jianghua Wang, Dong Jiang, Henghui Zhang, Sa Lv, Huiying Rao, Ran Fei, Lai Wei

    Hepatitis B virus (HBV) infection is a worldwide health problem and may develop to liver fibrosis, cirrhosis, and even hepatocellular carcinoma. To investigate the global proteome responses of liver‐derived cells to HBV infection and IFNα treatment, 2‐DE and MS‐based analysis were performed to compare the proteome changes between HBV stably transfected cell line HepG2.2.15 and its parental cell line HepG2, as well as HepG2.2.15 before and after IFNα treatment (5000 IU/mL for 72 h). Compared to HepG2, 12 of 18 down‐regulated and 27 of 32 up‐regulated proteins were identified in HepG2.2.15. After IFNα treatment, 6 of 7 down‐regulated and 11 of 14 up‐regulated proteins were identified. Differentially expressed proteins caused by HBV infection were involved with cytoskeletal matrix, heat shock stress, kinases/signal transduction, protease/proteasome components, etc. Prohibitin showed a dose‐dependent up‐regulation during IFNα treatment and might play a potent role in anti‐HBV activities of IFNα by enhancing the crossbinding p53 expression to achieve the apoptosis of HBV infected liver cells. Down‐regulation of interferon‐stimulated gene 15 (ISG15) in HepG2.2.15 and recovery by IFNα suggested its relationship with IFNα's anti‐HBV effect.